# Jiangsu NHWA Pharmaceutical Co., Ltd. – FDA Inspection, Apr 5, 2019

Source: https://www.keypedia.com/records/fda_inspections/jiangsu-nhwa-pharmaceutical-co-ltd/2b1249c1-70a2-4795-ba6b-b2cbf39b2784
Source feed: FDA_Inspections

> FDA inspection 1087127 of Jiangsu NHWA Pharmaceutical Co., Ltd., April 05, 2019. Classification: Official Action Indicated (OAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087127
- Company Name: Jiangsu NHWA Pharmaceutical Co., Ltd.
- Inspection Date: 2019-04-05
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1218183 - 2023-09-01](https://www.keypedia.com/records/fda_inspections/jiangsu-nhwa-pharmaceutical-co-ltd/43d116a8-3621-494b-a7f9-15b919ca0790)
- FDA Inspection 979725 - 2016-05-27

## Related Officers

- [Christopher S. Keating](https://www.keypedia.com/people/christopher-s-keating/94fcfd32-feb5-4b6c-80da-16202f4be01d)

Company: https://www.keypedia.com/companies/jiangsu-nhwa-pharmaceutical-co-ltd/7b3402dc-1e72-471c-ba50-33f225ac6625

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
